Ten63 Therapeutics
In silico drug design based on movement
Ten63 Therapeutics is a business in biopharma based in United States, founded in 2018.
Profile
Ten63 Therapeutics improves human health by developing potent therapeutics against medically-validated, yet “undruggable” targets. We do this by combining low-residual, ML-based computational chemistry and mathematically-guaranteed, superlinear search algorithms to find optimized drug candidates when no one else can.
As a business in biopharma, Ten63 Therapeutics is listed here with the public details available about it.
The business is associated with United States.
The company is listed at the SOSV portfolio company stage of development.
Its team size is recorded as 2-10 employees.
Total disclosed funding stands at about $2.6M.
| Sector | Biopharma |
|---|---|
| Country | United States |
| Founded | 2018 |
| Employees | 2-10 |
| Stage | SOSV portfolio company |
| Total funding | $2,570,000 |
Website: Ten63tx.com
Create a free account